Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Health Catalyst stock

HCAT
US42225T1079
A2PH3J

Price

7.70
Today +/-
+0.06
Today %
+0.91 %
P

Health Catalyst stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Health Catalyst stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Health Catalyst stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Health Catalyst stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Health Catalyst's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Health Catalyst Stock Price History

DateHealth Catalyst Price
10/4/20247.70 undefined
10/3/20247.63 undefined
10/2/20247.90 undefined
10/1/20248.05 undefined
9/30/20248.14 undefined
9/27/20248.31 undefined
9/26/20248.39 undefined
9/25/20248.23 undefined
9/24/20248.08 undefined
9/23/20248.20 undefined
9/20/20248.69 undefined
9/19/20248.83 undefined
9/18/20248.74 undefined
9/17/20248.70 undefined
9/16/20248.52 undefined
9/13/20248.44 undefined
9/12/20248.02 undefined
9/11/20247.95 undefined
9/10/20247.85 undefined
9/9/20247.48 undefined
9/6/20247.29 undefined

Health Catalyst Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Health Catalyst, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Health Catalyst from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Health Catalyst’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Health Catalyst. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Health Catalyst’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Health Catalyst’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Health Catalyst’s growth potential.

Health Catalyst Revenue, EBIT and net profit per share

DateHealth Catalyst RevenueHealth Catalyst EBITHealth Catalyst Net Income
2026e389.75 M undefined-13.64 M undefined42.23 M undefined
2025e349.34 M undefined-41.89 M undefined29.78 M undefined
2024e313.56 M undefined-53.5 M undefined22.5 M undefined
2023295.94 M undefined-86.96 M undefined-118.15 M undefined
2022276.2 M undefined-135.1 M undefined-137.4 M undefined
2021241.9 M undefined-115.8 M undefined-153.2 M undefined
2020188.8 M undefined-93.4 M undefined-115 M undefined
2019154.9 M undefined-54.4 M undefined-240.9 M undefined
2018112.6 M undefined-60.1 M undefined-114 M undefined
201773.1 M undefined-45.5 M undefined-58.8 M undefined

Health Catalyst Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20172018201920202021202220232024e2025e2026e
73112154188241276295313349389
-53.4237.5022.0828.1914.526.886.1011.5011.46
39.7346.4351.9547.8748.5548.5545.42---
29528090117134134000
-45-60-54-93-115-135-86-53-41-13
-61.64-53.57-35.06-49.47-47.72-48.91-29.15-16.93-11.75-3.34
-58-114-240-115-153-137-118222942
-96.55110.53-52.0833.04-10.46-13.87-118.6431.8244.83
35.135.118.739.547.553.756.42000
----------
Details

Keystats

ⓘ

Revenue and Growth

The Health Catalyst Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Health Catalyst is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
2017201820192020202120222023
             
51.533.2228.3270.9445363.5317.73
17.127.727.648.348.84860.29
0000000
0000000
2.95.98.410.614.616.315.38
71.566.8264.3329.8508.4427.8393.4
5.4118.137.644.442.639.64
0000000
0000000
29.628.325.598.9104.892.273.38
3.73.73.7107.8170186190.65
0.21.10.83.64.53.74.74
38.944.138.1247.9323.7324.5308.42
110.4110.9302.4577.7832.1752.3701.81
             
321.6409.8000.10.10.06
000.8111.41.421.48
-259.5-374.8-610.5-725.7-878.9-999-1,117.17
00100100-100-60033
0000000
62.135200.6276522.1425.1366.92
0.81.83.65.34.74.46.64
4.511.811.819.127.223.126.64
25.526.932.863.661.25555.75
0000000
01.300000
30.841.848.28893.182.589.03
9.618.848.2169180.9226.5228.03
0000000
7.815.35.344.63618.217.83
17.434.153.5213.6216.9244.7245.86
48.275.9101.7301.6310327.2334.9
110.3110.9302.3577.6832.1752.3701.81
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Health Catalyst provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Health Catalyst's financial health and stability.

Assets

Health Catalyst's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Health Catalyst must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Health Catalyst after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Health Catalyst's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2017201820192020202120222023
-47-61-60-115-153-137-118
57918374842
000-1-7-40
-113-3-34-13-13
10440113160144112
1354655
0000000
-36-40-32-26-23-35-33
-3-2-4-10-18-17-14
2221-209-82-139-3920
2523-205-72-121-2134
0000000
00-21143000
232821240270-12
2424231182264-22
1-340-1-6-10
0000000
105-1073101-76-10
-40.17-42.8-36.51-36.62-41.59-52.68-47.39
0000000

Health Catalyst stock margins

The Health Catalyst margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Health Catalyst. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Health Catalyst.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Health Catalyst's sales revenue. A higher gross margin percentage indicates that the Health Catalyst retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Health Catalyst's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Health Catalyst's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Health Catalyst's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Health Catalyst. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Health Catalyst's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Health Catalyst Margin History

Health Catalyst Gross marginHealth Catalyst Profit marginHealth Catalyst EBIT marginHealth Catalyst Profit margin
2026e45.56 %-3.5 %10.84 %
2025e45.56 %-11.99 %8.52 %
2024e45.56 %-17.06 %7.18 %
202345.56 %-29.38 %-39.92 %
202248.59 %-48.91 %-49.75 %
202148.7 %-47.87 %-63.33 %
202048.09 %-49.47 %-60.91 %
201952.23 %-35.12 %-155.52 %
201846.8 %-53.37 %-101.24 %
201740.22 %-62.24 %-80.44 %

Health Catalyst Stock Sales Revenue, EBIT, Earnings per Share

The Health Catalyst earnings per share therefore indicates how much revenue Health Catalyst has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Health Catalyst earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Health Catalyst's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Health Catalyst’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Health Catalyst's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Health Catalyst Revenue, EBIT and net profit per share

DateHealth Catalyst Sales per ShareHealth Catalyst EBIT per shareHealth Catalyst Earnings per Share
2026e6.45 undefined0 undefined0.7 undefined
2025e5.78 undefined0 undefined0.49 undefined
2024e5.19 undefined0 undefined0.37 undefined
20235.25 undefined-1.54 undefined-2.09 undefined
20225.14 undefined-2.52 undefined-2.56 undefined
20215.09 undefined-2.44 undefined-3.23 undefined
20204.78 undefined-2.36 undefined-2.91 undefined
20198.28 undefined-2.91 undefined-12.88 undefined
20183.21 undefined-1.71 undefined-3.25 undefined
20172.08 undefined-1.3 undefined-1.68 undefined

Health Catalyst business model

Health Catalyst Inc is a US-based company specializing in the analysis and management of healthcare data. The company was founded in 2008 by Tom Burton, Steve Barlow, and Dale Sanders in Salt Lake City and has since undergone impressive growth. Health Catalyst's story began with the goal of creating a better healthcare system based on strong data analysis and data-driven decision-making. The founders recognized that the lack of data analysis and consistent data quality in the healthcare industry led to inefficient processes and high costs. The company set out to solve these problems and contribute to better patient care and cost savings. Health Catalyst is divided into several divisions to offer a wide range of solutions for the healthcare industry. These include the areas of data and analytics platform, clinical decision support, population health management, and medical imaging. Health Catalyst's platform offers comprehensive data analysis and process improvements in key areas of business to support high-quality healthcare. In the field of clinical decision support, Health Catalyst provides analysis and tools to make clinical decisions based on data and evidence-based medicine. Health Catalyst's Population Health Management division helps insurers and healthcare providers optimize population health management based on data analysis to achieve better outcomes with reduced costs. In the medical imaging field, Health Catalyst offers solutions to improve workflow integration and quality improvements for medical images and data. Health Catalyst's products include the Analytics platform, a comprehensive platform for managing healthcare data for clinical, financial, and operational decision-making. Health Catalyst's clinical workflow applications support doctors and nurses in making informed decisions and providing optimal care to patients. Health Catalyst's product line for Population Health Management provides tools for risk assessment, population health analysis, and clinical decision support for insurance companies and healthcare providers. Health Catalyst's business model is based on the sale of software products, services, and subscriptions for the use of the healthcare data analytics platform. The company targets a broad customer base, including hospitals, clinics, healthcare providers, insurers, and government agencies. Health Catalyst has become a leading provider of healthcare data analytics and decision support systems. The company has built a global presence by offering solutions to healthcare companies worldwide. Health Catalyst has become a strong innovator in the industry by developing innovative technologies and integrating insights from its extensive data analysis into clinical and operational decisions. Overall, Health Catalyst has a strong vision for the future of healthcare. The company helps overcome the numerous challenges in the healthcare industry by focusing on data analytics and evidence-based decision-making. Health Catalyst's innovative technologies and solutions are expected to contribute to improving healthcare and making it more cost-effective in the coming years. Health Catalyst is one of the most popular companies on Eulerpool.com.

Health Catalyst Revenue by Segment

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Health Catalyst Revenue by Segment

Segmente20232022202120202019
Technology187.58 M USD176.29 M USD147.72 M USD110.47 M USD83.98 M USD
Professional services108.36 M USD99.95 M USD94.21 M USD78.38 M USD70.97 M USD
Recurring technology-175.81 M USD147.45 M USD110.47 M USD-
One-time technology (i.e., perpetual license)-480,000 USD272,000 USD--
Recurring technology187.23 M USD---83.79 M USD
One-time technology (i.e., perpetual license)357,000 USD---184,000 USD
Technology187.58 M USD176.29 M USD147.72 M USD110.47 M USD83.98 M USD
Professional services108.36 M USD99.95 M USD94.21 M USD78.38 M USD70.97 M USD

Health Catalyst SWOT Analysis

Strengths

Health Catalyst Inc. has a strong reputation in the healthcare industry, known for their data analytics solutions and expertise.

The company's software platform offers a comprehensive range of tools and features, providing advanced data-driven insights to healthcare organizations.

Health Catalyst Inc. has a talented and experienced team of data scientists and healthcare professionals, enabling them to develop innovative solutions tailored to meet the specific needs of their clients.

Weaknesses

One weakness of Health Catalyst Inc. is their relatively limited market presence compared to some larger competitors in the industry.

The company may face challenges in terms of scalability, as their solutions require significant infrastructure and resources to implement and maintain.

Health Catalyst Inc. may also struggle to keep up with the rapidly evolving technological landscape and changing healthcare regulations, which could impact the effectiveness of their solutions.

Opportunities

The increasing demand for data-driven healthcare solutions presents a significant opportunity for Health Catalyst Inc. to expand their market share and reach.

The company can leverage their expertise in data analytics to develop new products and services that cater to emerging healthcare trends and challenges.

Health Catalyst Inc. can also explore strategic partnerships and collaborations with other healthcare organizations to further enhance their offerings and broaden their customer base.

Threats

One of the major threats faced by Health Catalyst Inc. is the intense competition in the healthcare data analytics market, with numerous well-established players vying for market dominance.

Changes in healthcare policies and regulations can also pose a threat, as organizations may need to adapt or modify their software solutions to remain compliant.

Additionally, cyber threats and data breaches pose a significant risk to the company and its clients, requiring strong security measures and continuous monitoring.

Health Catalyst Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Health Catalyst historical P/E ratio, EBIT multiple, and P/S ratio

Health Catalyst shares outstanding

The number of shares was Health Catalyst in 2023 — This indicates how many shares 56.418 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Health Catalyst earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Health Catalyst's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Health Catalyst’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Health Catalyst's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Health Catalyst.

Health Catalyst latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20240.08 0.12  (48.33 %)2024 Q2
3/31/20240.03 0.05  (75.44 %)2024 Q1
12/31/20230 0.02  (2,757.14 %)2023 Q4
9/30/2023-0.02 0.03  (272.41 %)2023 Q3
6/30/2023-0 0.05  (1,415.79 %)2023 Q2
3/31/2023-0.04 0.05  (220.48 %)2023 Q1
12/31/2022-0.12 -0.05  (56.63 %)2022 Q4
9/30/2022-0.2 -0.13  (34.11 %)2022 Q3
6/30/2022-0.1 -0.03  (70.82 %)2022 Q2
3/31/2022-0.12 -0.06  (48.63 %)2022 Q1
1
2
3

Eulerpool ESG Scorecard© for the Health Catalyst stock

Eulerpool World ESG Rating (EESG©)

50/ 100

🌱 Environment

10

👫 Social

81

🏛️ Governance

58

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees40
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees18
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept❌
Privacy concept—
Occupational health and safety❌
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Health Catalyst shareholders

%
Name
Stocks
Change
Date
9.09256 % The Vanguard Group, Inc.5,498,272-933,73512/31/2023
6.94624 % BlackRock Institutional Trust Company, N.A.4,200,394351,08012/31/2023
6.87509 % Point72 Asset Management, L.P.4,157,366273,51412/31/2023
5.19312 % Wellington Management Company, LLP3,140,282139,68212/31/2023
3.17575 % Daventry Group, LP1,920,375346,20012/31/2023
2.90140 % Impax Asset Management LLC1,754,475600,00012/31/2023
2.55818 % Dimensional Fund Advisors, L.P.1,546,93266,61312/31/2023
2.34757 % PRIMECAP Management Company1,419,577299,13912/31/2023
2.12921 % State Street Global Advisors (US)1,287,532-172,97312/31/2023
2.08478 % Geode Capital Management, L.L.C.1,260,66880,05812/31/2023
1
2
3
4
5
...
10

Health Catalyst Executives and Management Board

Mr. Daniel Burton48
Health Catalyst Chief Executive Officer, Director (since 2011)
Compensation 4.44 M
Mr. Bryan Hunt36
Health Catalyst Chief Financial Officer
Compensation 3.19 M
Mr. Kevin Freeman50
Health Catalyst Chief Commercial Officer
Compensation 2.74 M
Ms. Linda Llewelyn56
Health Catalyst Chief People Officer
Compensation 1.14 M
Mr. John Kane70
Health Catalyst Independent Chairman of the Board
Compensation 247,567
1
2
3

Health Catalyst Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Snowflake A Stock
Snowflake A
SupplierCustomer-0,130,850,800,940,41-
Microsoft Stock
Microsoft
SupplierCustomer-0,650,370,600,91-0,170,11
1

Most common questions regarding Health Catalyst

What values and corporate philosophy does Health Catalyst represent?

Health Catalyst Inc is a leading provider of data and analytics solutions for healthcare organizations. The company represents values such as innovation, collaboration, and a patient-centric approach. With a focus on improving healthcare outcomes, Health Catalyst Inc emphasizes the importance of data-driven decision-making and empowering healthcare professionals with actionable insights. Their corporate philosophy revolves around driving meaningful change in the healthcare industry through leveraging advanced analytics and technology. By offering transformative solutions, Health Catalyst Inc aims to enable healthcare organizations to deliver better patient care, reduce costs, and enhance operational efficiency.

In which countries and regions is Health Catalyst primarily present?

Health Catalyst Inc is primarily present in the United States.

What significant milestones has the company Health Catalyst achieved?

Health Catalyst Inc, a leading healthcare analytics and data warehousing company, has achieved several significant milestones. Notably, the company successfully completed its initial public offering in July 2019, raising approximately $182 million. In 2020, Health Catalyst was named one of the Best Places to Work in Healthcare by Modern Healthcare. Furthermore, the company has consistently expanded its customer base, delivering data-driven solutions to over 150 healthcare organizations. Health Catalyst's innovative use of artificial intelligence and machine learning technologies has also gained recognition, contributing to the company's growth and success in improving healthcare outcomes.

What is the history and background of the company Health Catalyst?

Health Catalyst Inc is a leading provider of data and analytics in the healthcare industry. Founded in 2008, the company has quickly gained prominence for its innovative approach to improving healthcare outcomes through data-driven insights. Health Catalyst offers a comprehensive suite of solutions designed to help healthcare organizations organize, analyze, and leverage their data to drive decision-making and improve patient care. With a strong focus on value-based care and population health management, Health Catalyst has established itself as a trusted partner for healthcare organizations seeking to transform their operations and achieve better patient outcomes.

Who are the main competitors of Health Catalyst in the market?

Some of the main competitors of Health Catalyst Inc in the market include Cerner Corporation, Epic Systems Corporation, Allscripts Healthcare Solutions, and McKesson Corporation.

In which industries is Health Catalyst primarily active?

Health Catalyst Inc is primarily active in the healthcare industry.

What is the business model of Health Catalyst?

The business model of Health Catalyst Inc is focused on providing data and analytics solutions to healthcare organizations. The company aims to enable these organizations in improving patient outcomes, reducing costs, and enhancing operational efficiency by leveraging their vast amount of healthcare data. Health Catalyst offers a comprehensive suite of products and services, including a data platform, analytics applications, and expertise in areas such as quality measures, population health management, and care coordination. By utilizing advanced data analytics, Health Catalyst assists healthcare organizations in making informed decisions, identifying areas for improvement, and ultimately transforming the way healthcare is delivered.

What is the P/E ratio of Health Catalyst 2024?

The Health Catalyst P/E ratio is 19.31.

What is the P/S ratio of Health Catalyst 2024?

The Health Catalyst P/S ratio is 1.39.

What is the AlleAktien quality score of Health Catalyst?

The AlleAktien quality score for Health Catalyst is 3/10.

What is the revenue of Health Catalyst 2024?

The expected Health Catalyst revenue is 313.56 M USD.

How high is the profit of Health Catalyst 2024?

The expected Health Catalyst profit is 22.5 M USD.

What is the business model of Health Catalyst

Health Catalyst Inc is a US-based company specializing in the development of clinical analytics platforms. The company offers solutions for healthcare data analysis and data-driven decision support. Its business model is based on providing software and analytics tools to manage, integrate, analyze, and visualize clinical data. By combining the latest technologies in data analytics and business intelligence with deep expertise in healthcare, Health Catalyst supports hospitals and health systems in improving patient care. The company consists of two main divisions: data warehousing and analytics. The data warehousing division involves developing and managing databases and integrating data from various sources to obtain a comprehensive view of a facility's clinical performance and enable informed decision-making. The analytics division focuses on implementing analytics tools and methods to analyze the collected data and transform it into meaningful insights. Health Catalyst's product range includes solutions for population health management, improving clinical outcomes, and reducing healthcare costs. This includes clinical analytics and visualization tools, population health management platforms, data integration and storage solutions, and healthcare analytics services. The Health Catalyst data platform is an open system capable of processing both structured and unstructured data in real-time. This allows customers to easily integrate and analyze their data for informed decision-making. The target customers of Health Catalyst are hospitals and health systems in the United States facing increasing competitive pressure and growing demand for high-quality patient care. The company addresses the need to reduce healthcare costs, improve patient care, and optimize health processes. Health Catalyst's business model relies on recurring revenue from selling subscriptions to use the software platform and providing analytics tools and services. Additionally, the company offers training, consulting services, and technical support. In summary, Health Catalyst creates value for its customers by providing advanced tools to improve healthcare and achieve cost savings. The company's business model is also focused on recurring subscription revenue and additional service fees. By focusing on improving clinical outcomes, Health Catalyst demonstrates enthusiasm for healthcare and a passionate commitment to enhancing patient well-being.

What is the Health Catalyst dividend?

Health Catalyst pays a dividend of 0 USD distributed over payouts per year.

How often does Health Catalyst pay dividends?

The dividend cannot currently be calculated for Health Catalyst or the company does not pay out a dividend.

What is the Health Catalyst ISIN?

The ISIN of Health Catalyst is US42225T1079.

What is the Health Catalyst WKN?

The WKN of Health Catalyst is A2PH3J.

What is the Health Catalyst ticker?

The ticker of Health Catalyst is HCAT.

How much dividend does Health Catalyst pay?

Over the past 12 months, Health Catalyst paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Health Catalyst is expected to pay a dividend of 0 USD.

What is the dividend yield of Health Catalyst?

The current dividend yield of Health Catalyst is .

When does Health Catalyst pay dividends?

Health Catalyst pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Health Catalyst?

Health Catalyst paid dividends every year for the past 0 years.

What is the dividend of Health Catalyst?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Health Catalyst located?

Health Catalyst is assigned to the 'Health' sector.

Wann musste ich die Aktien von Health Catalyst kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Health Catalyst from 10/5/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/5/2024.

When did Health Catalyst pay the last dividend?

The last dividend was paid out on 10/5/2024.

What was the dividend of Health Catalyst in the year 2023?

In the year 2023, Health Catalyst distributed 0 USD as dividends.

In which currency does Health Catalyst pay out the dividend?

The dividends of Health Catalyst are distributed in USD.

All fundamentals about Health Catalyst

Our stock analysis for Health Catalyst Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Health Catalyst Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.